970 results on '"Derweesh, Ithaar H."'
Search Results
2. Robot-assisted laparoscopic nephrectomy: early outcome measures with the implementation of multimodal analgesia and intrathecal morphine via the acute pain service
3. Combined Charlson comorbidity/C-Reactive Protein Index Is a Novel Predictor in Renal Cell Carcinoma: Analysis of the International Marker Consortium for Renal Cancer (INMARC) Registry
4. Survival Outcomes by Race Following Surgical Treatment for Upper Tract Urothelial Carcinoma
5. Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry
6. Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
7. Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome
8. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group
9. Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis
10. A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors
11. Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR
12. Predictive factors for recurrence and outcomes in T1a renal cell carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) database
13. Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)
14. MP36-17 RENAL FUNCTIONAL IMPROVEMENT AFTER PARTIAL NEPHRECTOMY: PREDICTORS AND CONSEQUENCES
15. PD20-05 REAL-WORLD DATA: CALL FOR PARADIGM SHIFT TOWARDS NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY—ANALYSIS OF THE ROBUUST REGISTRY
16. MP36-06 COMBINATION OF CHARLSON COMORBIDITY INDEX AND C-REACTIVE PROTEIN IS ASSOCIATED WITH IMPROVED PROGNOSTIC PERFORMANCE COMPARED TO CHARLSON COMORBIDITY INDEX ALONE IN RENAL CELL CARCINOMA
17. PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS
18. MP10-11 A PROPENSITY SCORE-MATCHED ANALYSIS OF OUTCOMES OF NEOADJUVANT AND ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA: IMPACT OF TIMING OF THERAPY AND POSITIVE MARGIN
19. MP51-10 FUNCTIONAL OUTCOMES IN RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE VERSUS PARTIAL NEPHRECTOMY: A PROPENSITY SCORE MATCHED ANALYSIS
20. MP36-05 NODESAFE NOMOGRAM: A NOVEL SCORE SYSTEM TO PREDICT LYMPH NODE INVOLVEMENT AT THE TIME OF NEPHRECTOMY OR NODAL RECURRENCE IN NON-METASTATIC RENAL CELL CARCINOMA
21. MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA
22. MP67-16 PREOPERATIVE ESTIMATION MODEL FOR PATHOLOGICAL T3 UPSTAGING IN PATIENTS WITH CLINICAL T1-2 CLEAR CELL RENAL CELL CARCINOMA UNDERWENT SURGERY: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER (INMARC)
23. MP38-03 PREDICTORS AND OUTCOME OF LYMPH NODE INVOLVEMENT FOLLOWING NEOADJUVANT CHEMOTHERAPY AND RADICAL NEPHROURETERECTOMY FOR PRIMARY UPPER TRACT UROTHELIAL CARCINOMA (ROBUUST COLLABORATIVE GROUP)
24. MP36-10 UNRAVELING THE “OBESITY PARADOX” IN RENAL CORTICAL TUMORS: INSIGHTS FROM THE INMARC REGISTRY
25. PD20-04 ROBOTIC DISTAL URETERECTOMY FOR HIGH-RISK DISTAL URETERAL UROTHELIAL CARCINOMA: A RETROSPECTIVE MULTICENTER COMPARATIVE ANALYSIS (ROBUUST COLLABORATIVE ANALYSIS)
26. PD11-01 TRENDS AND COSTS OF MINIMALLY INVASIVE RENAL SURGERY FOR KIDNEY CANCER: A NATIONAL POPULATION-BASED STUDY
27. MP38-17 REAL-WORLD MANAGEMENT OF HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA: LEVEL OF ADHERENCE TO EAU-AUA GUIDELINES—ANALYSIS OF THE ROBUUST REGISTRY
28. MP67-20 OPEN SURGERY VS MINIMALLY INVASIVE SURGERY FOR RENAL CELL CARCINOMA: A PROPENSITY-SCORE-MATCHING COMPARISON OF FUNCTIONAL OUTCOMES
29. MP38-18 DECISIONAL AND PROGNOSTIC IMPACT OF DIAGNOSTIC URETEROSCOPY IN HIGH-RISK UPPER TRACT UROTHELIAL CARCINOMA: A MULTI-INSTITUTIONAL COLLABORATIVE ANALYSIS (ROBUUST COLLABORATIVE GROUP)
30. MP44-09 PROGNOSTIC NOMOGRAMS INCORPORATING PREOPERATIVE CRP LEVEL FOR PREDICTING SURVIVAL OUTCOMES IN PATIENTS WITH NONMETASTATIC CLEAR CELL RENAL CELL CARCINOMA: INMARC STUDY
31. Rising Serum Uric Acid Level Is Negatively Associated with Survival in Renal Cell Carcinoma
32. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry
33. Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort
34. Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry
35. Can multiphase CT scan distinguish between papillary renal cell carcinoma type 1 and type 2?
36. Prognostic Significance of Pancreatic Metastases in Patients With Advanced Renal Cell Carcinoma Treated With Systemic Therapy
37. C-REACTIVE PROTEIN KINETICS ARE ASSOCIATED WITH PROGRESSION AND SURVIVAL IN SURGICALLY TREATED RENAL CELL CARCINOMA PATIENTS
38. IMPACT OF OBESITY ON SURGICALLY-INDUCED RENAL FUNCTIONAL DECLINE FOLLOWING RADICAL AND PARTIAL NEPHRECTOMY: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER (INMARC) DATABASE
39. DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA
40. IS PATHOLOGICAL UPSTAGING TO T3A RENAL CELL CARCINOMA ASSOCIATED WITH A SIMILAR PROGNOSIS TO NON-UPSTAGED PATHOLOGIC T3A DISEASE? A MULTICENTER ANALYSIS
41. COMPARATIVE ANALYSIS OF ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF RADICAL AND PARTIAL NEPHRECTOMY IN PT3AN0M0 RENAL CELL CARCINOMA: A MULTICENTER PROPENSITY SCORE-MATCHED ANALYSIS
42. SHIFTING THE PARADIGM: THE INTRIGUING ROLE OF C-REACTIVE PROTEIN IN RENAL CELL CARCINOMA STAGING WITHIN THE AJCC SYSTEM -ANALYSIS OF THE INMARC REGISTRY
43. NEOADJUVANT CHEMOTHERAPY AND RADICAL NEPHROURETERECTOMY (RNU) VS. RNU ALONE FOR UPPER TRACT UROTHELIAL CARCINOMA: A MULTI-INSTITUTIONAL COHORT ANALYSIS (ROBUUST COLLABORATIVE)
44. DEVELOPMENT OF NODESAFE A NOVEL SCORE SYSTEM TO PREDICT LYMPH NODE METASTASIS OR RECURRENCE AT THE TIME OF OR FOLLOWING NEPHRECTOMY.
45. ASSOCIATION BETWEEN SMOKING BURDERN AND ONCOLOGIC OUTCOMES OF UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST COLLABORATION
46. HYPERTENSION IS ASSOCIATED WITH WORSENED ONCOLOGICAL SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEPHRECTOMY FOR RENAL CELL CARCINOMA: ANALYSIS OF THE INMARC REGISTRY
47. DEVELOPMENT OF A NOVEL NOMOGRAM TO PREDICT BENIGN LESION PATHOLOGY IN PATIENTS AFFECTED BY RENAL MASSES: ANALYSIS OF THE INMARC REGISTRY.
48. INCORPORATING C-REACTIVE PROTEIN INTO THE TRIFECTA: IMPLICATIONS FOR SURVIVAL AND FUNCTIONAL OUTCOMES FOLLOWING PARTIAL NEPHRECTOMY
49. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis
50. Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.